Outcome measures in ankylosing spondylitis;Instrumentos de avaliação em espondilite anquilosante

Revista Brasileira de Reumatologia

Volumn 46, Issue SUPPL. 1, 2006, Pages 52-59

  Torres, Themis Mizerkowski ^a,b   Ciconelli, Rozana Mesquita ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Ankylosing spondylitis; Instruments; Quality of life

Indexed keywords

CORTICOSTEROID; NONSTEROID ANTIINFLAMMATORY AGENT;

ANKYLOSING SPONDYLITIS; CONSENSUS DEVELOPMENT; DISABILITY SEVERITY; DISEASE ACTIVITY; EVIDENCE BASED MEDICINE; FUNCTIONAL ASSESSMENT; HUMAN; OUTCOME ASSESSMENT; QUALITY OF LIFE; REVIEW; SHORT FORM 36; SPINE RADIOGRAPHY; TREATMENT INDICATION;

EID: 51549093973     PISSN: 04825004     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0482-50042006000700009     Document Type: Review

References (36)

1. Braun J, Bollow M, Remlinger G, Eggens U, Rudwaleit M, Distler A et al: Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors. Arthritis Rheum 41: 58-67, 1998.
2. Braun J, Sieper J: Inception cohorts for spondyloarthropathies. Z Rheumatol 59:11, 2000.
3. Zink A, Braun J, Listing J, Wollenhaupt J: Disability and handicap in rheumatoid arthritis and ankylosing spondylitis - results from the German rheumatological database. J Rheumatol 27: 613-22, 2000.
4. Braun J, Brandt J, Listing J, Zink A, Alten R, Krause A et al. Treatment of active ankylosing spondylitis with infliximab - a double-blind, placebo-controlled multicenter trial. Lancet 359:1187-93, 2002
5. Gorman JD, Sack KE, Davis JC Jr: Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor α. N Engl J Med 346: 1349-56, 2002.
6. Barkham N, Kong KO, Tennant A et al: The unmet need for anti-tumour necrosis factor (anti-TNF) therapy in ankylosing spondylitis. Rheumatology (Oxford) 44: 1277-81, 2005.
7. Ciconelli R.M. Medidas de avaliação de qualidade de vida: Rev Bras Reum 43: IX - XIII, 2003.
8. Calin A, Nakache JP, Gueguen A et al: Defining disease activity in ankylosing spondylitis: is a combination of variables (Bath Ankylosing Spondylitis Disease Activity Index) an appropriate instrument? Rheumatology 38: 878-882, 1999.
9. Calin A, Garrett S, Whitelock H et al: A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21: 2281-5, 1994.
10. van der Heijde D, Bellamy N, Calin A et al: Preliminary core sets for endpoints in ankylosing spondylitis. Assessments in Ankylosing Spondylitis Working Group. J Rheumatol 24: 2225-9, 1997.
11. van der Heijde D, Bellamy N, Calin A et al: Selection of instruments in the core set for DC-ART, SMARD, physical therapy, and clinical record keeping in ankylosing spondylitis. Progress report of the ASAS Working Group. Assessments in Ankylosing Spondylitis. J Rheumatol 26: 951-4, 1999.
12. Calin A, Mackay K, Santos H, Brophy S: A new dimension to outcome: application of the Bath Ankylosing Spondylitis Radiology Index. J Rheumatol. 26: 988-92, 1999.
13. Jones SD, Steiner A, Garrett SL, Catin A. The Bath Ankylosing Spondylitis Patient Global Score (BAS-G): Br J Rheumatol. 35: 66-71, 1996.
14. Jenkinson TP, Mallorie PA, Whitelock H et al: Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrology Index. J Rheumatol 21: 1694-8, 1994.
15. Doward LC, Spoorenberg A, Cook SA et al: Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis. Ann Rheum Dis 62: 20-6, 2003.
16. Daltroy LH, Larson MG, Roberts WN, Liang MH: A Modification of the Health Assessment Questionnaire for the Spondyloarthropathies. J Rheumatol 17: 946-50, 1990.
17. Guillemin F, Challier B, Urlacher F et al: Quality of life in ankylosing spondylitis: validation of the ankylosing spondylitis Arthritis Impact Measurement Scales 2, a modified Arthritis Impact Measurement Scales Questionnaire. Arthritis Care Res 12: 157-62, 1999.
18. Dougados M, Gueguen A, Nakache JP et al: Evaluation of a functional index and an articular index in ankylosing spondylitis. J Rheumatol 15: 302-7, 1998.
19. Haywood KL, Garratt AM, Dziedzic K, Dawes PT: Patient centered assessment of ankylosing spondylitis-specific health related quality of life: evaluation of the Patient Generated Index. J Rheumatol 30: 764-73, 2003.
20. Haywood KL, M Garratt A, Jordan K et al: Disease-specific, patient-assessed measures of health outcome in ankylosing spondylitis: reliability, validity and responsiveness. Rheumatology (Oxford) 41: 1295-302, 2002
21. Averns HL, Oxtoby J, Taylor HG, Jones PW, Dziedzic K, Dawes PT: Radiological outcome in ankylosing spondylitis: use of the Stoke Ankylosing Spondylitis Spine Score (SASSS). Br J Rheumatol 35: 373-6, 1996.
22. Creemers MC, Franssen MJ, van 't Hof MA, Gribnau FW, van de Putte LB, van Riel PL: A radiographic scoring system and identification of variables measuring structural damage in ankylosing spondylitis [thesis]. Nijmegen (The Netherlands): University of Nijmegen;1993.
23. Wanders AJ, Landewe RB, Spoorenberg A, Dougados M, van der Linden S, Mielants H, et al: What is the most appropriate radiologic scoring method for ankylosing spondylitis? A comparison of the available methods based on the Outcome Measures in Rheumatology Clinical Trials filter. Arthritis Rheum 50:2622-32, 2004
24. Ciconelli RM, Ferraz MB, Santos W et al: Tradução para a língua portuguesa e validação do questionário genérico de avaliação de qualidade de vida SF-36 (Brasil SF-36). Rev. Bras Reumatol 39:143-50, 1999.
25. Haywood KL, Garratt AM, Dziedzic K, Dawes PT: Generic measures of health-related quality of life in ankylosing spondylitis: reliability, validity and responsiveness. Rheumatology (Oxford) 41: 1380-7, 2002
26. van Tubergen A, Landewe R, Heuft-Dorenbosch L et al: Assessment of disability with the World Health Organisation Disability Assessment Schedule II in patients with ankylosing spondylitis. Ann Rheum Dis 62:140-5, 2003.
27. OMERACT IV Conference. Cancan, Mexico. J Rheumatol Suppl, 1998.
28. van der Heijde D, Braun J, McGonagle D, Siegel J: Treatment trials in ankylosing spondylitis: current and future considerations. Ann Rheum Dis 61 (Suppl III): iii24-iii32, 2002.
29. Ruof J, Stucki G: Comparison of the Dougados Functional Index and the Bath Ankylosing Spondylitis Functional Index. A literature review. J Rheumatol 26: 955-60, 1999.
30. Mander M, Simpson JM, McLellan A et al: Studies with an enthesis index as a method of clinical assessment in ankylosing spondylitis.Ann Rheum Dis 46: 197-202, 1987.
31. Heuft-Dorenbosch L, Spoorenberg A, van Tubergen A et al: Assessment of enthesitis in ankylosing spondylitis. Ann Rheum Dis 62: 127-32, 2003.
32. Spoorenberg A, van der Heijde D, de Klerk E et al: Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis. J Rheumatol 26: 980-4, 1999.
33. Braun J, Baraliakos X, Golder W et al: Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis, before and after successful therapy with infliximab: evaluation of a new scoring system. Arthritis Rheum 48: 1126-1136, 2003.
34. van Tubergen A, Coenen J, Landewe R, Spoorenberg A, Chorus A, Boonen A, van der Linden S, van der Heijde D: Assessment of fatigue in patients with ankylosing spondylitis: a psychometric analysis. Arthritis Rheum 47: 8-16, 2002.
35. Anderson JJ, Baron G, van der Heijde D, Felson DT, Dougados M: Ankylosing spondylitis assessment group preliminary definition of short-term improvement in ankylosing spondylitis. Arthritis Rheum 44: 1876-86, 2001.
36. Braun J, Pham T, Sieper J, Davis J, van der Linden S, Dougados M, van der Heijde D; ASAS Working Group. International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis. Ann Rheum Dis 62: 817-24, 2003.